샘플 요청 목록

 카트 문의
시장보고서
상품코드
1536126

세계의 자궁 경부 근긴장 이상 치료 시장

Cervical Dystonia Treatment
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 282 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 자궁 경부 근긴장 이상 치료 시장은 2030년까지 6억 9,350만 달러에 달할 전망

2023년에 5억 290만 달러로 평가된 세계의 자궁 경부 근긴장 이상 치료 시장은 2030년에는 6억 9,350만 달러에 이를 전망이며, 분석 기간 2023년부터 2030년까지 CAGR은 4.7%로 성장할 것으로 예측됩니다. 보툴리눔툭신(보톡스) 주사는 본 보고서에서 분석한 부문 중 하나이며 CAGR은 4.6%로 성장을 지속하고, 분석 기간 종료 시 2억 8,440만 달러에 달할 것으로 예측됩니다. 경구 약물 부문의 성장률은 분석 기간 동안 CAGR 6.8%로 추정됩니다.

미국 시장은 1억 3,700만 달러로 추정, 중국은 CAGR 7.7%로 성장할 것으로 예측

미국의 자궁 경부 근긴장 이상 치료 시장은 2023년 1억 3,700만 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 2023년부터 2030년까지 CAGR 7.7%로 성장을 지속할 전망이며, 2030년에는 1억 4,190만 달러 규모에 이를 것으로 예측되고 있습니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 1.8%와 4.9%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 2.8%로 성장할 것으로 예측됩니다.

세계의 자궁 경부 근긴장 이상 치료 시장-주요 동향 및 촉진요인 요약

경련 경사라고도 알려진 자궁 경부 근긴장 근육은 경부의 불수의 근육 수축을 특징으로 하는 신경 질환으로 머리의 비정상적인 움직임과 자세로 이어집니다. 이 질환은 심각한 통증과 불편함을 유발하여 사람의 삶의 질에 영향을 미칩니다. 자궁 경부 근긴장 이상 치료의 첫 번째 목표는 근육 수축의 중증도를 낮추고 통증을 완화하고 기능 능력을 향상시키는 것입니다. 보툴리눔툭신(보톡스) 주사(보톡스, 디스포트, 제오민 등)는 가장 일반적으로 사용되는 효과적인 치료법입니다. 이러한 주사는 근육 수축을 일으키는 신경 신호를 차단함으로써 효과를 발휘하며, 몇 개월에 걸쳐 완화를 가져옵니다. 항콜린제, 근이완제, 벤조디아제핀계 약제 등의 내복약도 사용되지만, 그 효과는 다양하고 부작용을 수반하는 경우도 많습니다. 더 심한 경우에는 뇌의 특정 부위에 전극을 삽입하여 비정상 신호를 조절하는 뇌 심부 자극 요법(DBS)과 같은 외과적 개입도 고려됩니다.

자궁 경부 근긴장 이상 치료의 최근 발전으로 환자의 예후가 크게 개선되었습니다. 보다 정교한 보툴리눔툭신(보톡스) 제형 및 주입 기술의 개발은 이 치료의 정확성과 효과를 향상시켰습니다. 게다가, 초음파와 근전도(EMG) 지침의 출현으로 임상의는 이환된 근육을 보다 정확하게 표적화할 수 있게 되어 더 나은 결과와 부작용을 줄일 수 있습니다. 근긴장 근본적인 메커니즘에 대한 조사를 통해 유전자 치료 및 신경 보호제와 같은 새로운 치료법에 대한 길도 열렸습니다. 물리 치료 및 작업 치료와 같은 재활 치료는 자궁 경부 근긴장 관리에 중요한 역할을 합니다. 이러한 치료법은 스트레칭과 근력 강화 운동, 자세 교정, 통증 관리 전략에 중점을 두고 전반적인 기능과 삶의 질을 향상시키는 약물 치료를 보완합니다.

자궁 경부 근긴장 이상 치료 시장의 성장은 여러 요인에 의해 발생합니다. 이 질병에 대한 인식과 진단 증가는 효과적인 치료에 대한 수요 증가로 이어지고 있습니다. 보툴리눔툭신(보톡스) 제제와 주입 기술의 개량 등 의료 기술의 진보가 치료 효과와 환자의 만족도를 높이고 있습니다. 신경질환의 유병률 상승과 고령화도 시장 확대에 기여하고 있습니다. 게다가, 현재 진행 중인 연구개발은 유전자 치료 및 새로운 약리학적 약제와 같은 새로운 혁신적인 치료 옵션을 도입하고 있습니다. 원격 의료와 디지털 건강 플랫폼의 통합은 더 나은 환자 관리와 후속 관리를 촉진하고 보급을 촉진합니다. 게다가, 디스토니아 치료에 대한 건강 관리 정책과 보험 적용이 뒷받침되어 이러한 치료가 더 이용하기 쉬워지고 있습니다. 이러한 추세가 계속 진화함에 따라 자궁 경부 근긴장 이상 치료 시장은 기술 진보와 환자 중심의 종합적 치료의 중요성이 커짐에 따라 지속적인 성장이 예상됩니다.

조사 대상 기업 예(전 86건)

  • AbbVie, Inc.
  • AEON Biopharma
  • Eisai Co., Ltd.
  • Ipsen Pharma
  • Merz Therapeutics GmbH
  • Revance Therapeutics, Inc.
  • Supernus Pharmaceuticals, Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향 및 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

AJY 24.09.06

Global Cervical Dystonia Treatment Market to Reach US$693.5 Million by 2030

The global market for Cervical Dystonia Treatment estimated at US$502.9 Million in the year 2023, is expected to reach US$693.5 Million by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Botulinum Toxin Injections, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$284.4 Million by the end of the analysis period. Growth in the Oral Medications segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$137.0 Million While China is Forecast to Grow at 7.7% CAGR

The Cervical Dystonia Treatment market in the U.S. is estimated at US$137.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$141.9 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Cervical Dystonia Treatment Market - Key Trends and Drivers Summarized

Cervical dystonia, also known as spasmodic torticollis, is a neurological disorder characterized by involuntary muscle contractions in the neck, leading to abnormal movements and postures of the head. This condition can cause significant pain and discomfort, affecting a person's quality of life. The primary goal of treatment for cervical dystonia is to reduce the severity of muscle contractions, alleviate pain, and improve functional abilities. Botulinum toxin injections (e.g., Botox, Dysport, Xeomin) are the most commonly used and effective treatment. These injections work by blocking the nerve signals that cause muscle contractions, providing relief for several months. Oral medications such as anticholinergics, muscle relaxants, and benzodiazepines are also used, though their effectiveness varies and they often come with side effects. In more severe cases, surgical interventions such as deep brain stimulation (DBS) may be considered, where electrodes are implanted in specific areas of the brain to regulate abnormal signals.

Recent advancements in the treatment of cervical dystonia have significantly improved patient outcomes. The development of more refined botulinum toxin formulations and injection techniques has enhanced the precision and effectiveness of this therapy. Additionally, the advent of ultrasound and electromyography (EMG) guidance has enabled clinicians to target affected muscles more accurately, leading to better results and reduced side effects. Research into the underlying mechanisms of dystonia has also paved the way for potential new treatments, including gene therapy and neuroprotective agents. Rehabilitation therapies, including physical therapy and occupational therapy, play a crucial role in managing cervical dystonia. These therapies focus on stretching and strengthening exercises, posture correction, and pain management strategies, complementing pharmacological treatments to improve overall functionality and quality of life.

The growth in the cervical dystonia treatment market is driven by several factors. Increasing awareness and diagnosis of the condition are leading to higher demand for effective treatments. Advances in medical technology, such as improved botulinum toxin formulations and injection techniques, are enhancing treatment efficacy and patient satisfaction. The rising prevalence of neurological disorders and an aging population are also contributing to market expansion. Moreover, ongoing research and development efforts are introducing new and innovative treatment options, including potential gene therapies and novel pharmacological agents. The integration of telemedicine and digital health platforms is facilitating better patient management and follow-up care, driving adoption. Additionally, supportive healthcare policies and insurance coverage for dystonia treatments are making these therapies more accessible. As these trends continue to evolve, the cervical dystonia treatment market is expected to experience sustained growth, driven by technological advancements and a growing emphasis on comprehensive, patient-centered care.

Select Competitors (Total 86 Featured) -

  • AbbVie, Inc.
  • AEON Biopharma
  • Eisai Co., Ltd.
  • Ipsen Pharma
  • Merz Therapeutics GmbH
  • Revance Therapeutics, Inc.
  • Supernus Pharmaceuticals, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cervical Dystonia Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Awareness and Diagnosis of Cervical Dystonia Expands Addressable Market Opportunity
    • Advances in Botulinum Toxin Formulations Propel Market Growth
    • Improved Injection Techniques Strengthen Business Case for Botulinum Toxin Treatments
    • Integration of Ultrasound and EMG Guidance Enhances Treatment Precision
    • Rising Prevalence of Neurological Disorders Drives Demand for Effective Therapies
    • Aging Population Generates Increased Need for Cervical Dystonia Treatments
    • Development of Gene Therapy Options Throws the Spotlight on Innovative Treatments
    • Enhanced Rehabilitation Therapies Accelerate Demand for Comprehensive Care Solutions
    • Research into Neuroprotective Agents Expands Treatment Horizons
    • Telemedicine and Digital Health Platforms Drive Adoption of Remote Patient Management
    • Increasing Patient Preference for Minimally Invasive Treatments Propels Growth
    • Improved Patient Outcomes with Advanced Therapeutics Strengthen Market Dynamics
    • Focus on Pain Management Solutions Generates Demand for Multi-modal Therapies
    • Development of Personalized Treatment Plans Drives Adoption of Targeted Therapies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cervical Dystonia Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cervical Dystonia Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cervical Dystonia Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Botulinum Toxin Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Botulinum Toxin Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Botulinum Toxin Injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Oral Medications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Oral Medications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Oral Medications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Deep Brain Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Clinics & Rehabilitation Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Clinics & Rehabilitation Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Clinics & Rehabilitation Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Home Care End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Home Care End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Home Care End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • JAPAN
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • CHINA
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • EUROPE
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Cervical Dystonia Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Cervical Dystonia Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • FRANCE
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • GERMANY
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Cervical Dystonia Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Cervical Dystonia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • INDIA
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Cervical Dystonia Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Cervical Dystonia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Cervical Dystonia Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Cervical Dystonia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • AFRICA
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제